Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells

Food and Chemical Toxicology

Volumn 43, Issue 11, 2005, Pages 1619-1625

  Whittaker, Paul ^a   San, Richard H C ^b   Clarke, Jane J ^b   Seifried, Harold E ^c   Dunkel, Virginia C ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b BioReliance   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chromium; Chromium picolinate; Mouse lymphoma; Mutagenicity; Salmonella typhimurium

Indexed keywords

CHROMIUM CHLORIDE; CHROMIUM PICOLINATE; PICOLINIC ACID;

ANIMAL CELL; ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; LEUKEMIA L 5178 Y; LYMPHOMA CELL; MOUSE; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; SALMONELLA TYPHIMURIUM;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMIUM; CRICETINAE; LIVER; LYMPHOMA; MESOCRICETUS; MICE; MUTAGENICITY TESTS; MUTAGENS; PICOLINIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM; TUMOR STEM CELL ASSAY;

ANIMALIA; SALMONELLA TYPHIMURIUM;

EID: 24644443253     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2005.05.003     Document Type: Article

References (23)

1. Agency for Toxic Substances and Disease Registry (ATSDR)., 1998. Toxicological profile for chromium (update). Centers for Disease Control and Prevention, Atlanta.
2. B.N. Ames, J. McCann, and E. Yamasaki Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test Mutat. Res. 31 1975 347 364
3. D. Bagchi, S.J. Stohs, B.W. Downs, M. Bagchi, and H.G. Preuss Cytotoxicity and oxidative mechanisms of different forms of chromium Toxicology 180 2002 5 22
4. D. Clive, and J.F.S. Spector Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y TK+/- mouse lymphoma cells Mutat. Res. 31 1975 17 29
5. D. Clive, K.O. Johnson, J.F.S. Spector, A.G. Batson, and M.M.M. Brown Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system Mutat. Res. 59 1979 61 108
6. D. Clive, G. Bolcsfoldi, J. Clements, J. Cole, M. Homn, J. Majeska, M. Moore, L. Muller, B. Myhr, T. Oberly, M. Oudelhkim, C. Rudd, H. Shimada, T. Sofuni, V. Thybaud, and P. Wilcox Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994 Environ. Mol. Mutagen. 25 1995 165 168
7. Code of Federal Regulations: Title 21. Part 101.9(c) (8) (iv). 2004. US Government Printing Office, Washington, DC.
8. C.M. Davis, and J.B. Vincent Chromium oligopeptide activates insulin receptor tyrosine kinase activity Biochemistry 36 1997 4382 4385
9. Food and Nutrition Board, Institute of Medicine Chromium Dietary Reference Intakes for Vitamin A, Vitamin C, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2002 National Academy Press Washington, DC 197 223
10. D.D.D. Hepburn, and J.B. Vincent Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream J. Inorg. Biochem. 94 2003 86 93
11. S.A. Kareus, C. Kelley, H.S. Walton, and P.R. Sinclair Release of Cr(III) from Cr(III) picolinate upon metabolic activation J. Hazard. Mater. 84 2001 163 174
12. A.G. Levis, and F. Majone Cytotoxic and clastogenic effects of soluble chromium compounds on mammalian cell cultures Br. J. Cancer 40 1979 523 533
13. K.R. Manygoats, M. Yazzie, and D.M. Stearns Ultrastructural damage in chromium picolinate-treated cells: a TEM study J. Biol. Inorg. Chem. 7 2002 791 798
14. National Toxicology Program (NTP). Available form: 〈 http://ntp.niehs.nih.gov/ntweb /〉.
15. R.F. Newbold, J. Amos, and J.R. Connell The cytotoxic, mutagenic and clastogenic effects of chromium-containing compounds on mammalian cells in culture Mutat. Res. 67 1979 55 63
16. G. Raffetto, S. Parodi, C. Parodi, M. De Ferrari, R. Troiano, and G. Brambilla Direct interaction with cellular targets as the mechanism for chromium carcinogenesis Tumori 63 1977 503 512
17. J.K. Speetjens, R.A. Collins, J.B. Vincent, and S.A. Woski The nutritional supplement chromium (III) tris(picolinate) cleaves DNA Chem. Res. Toxicol. 12 1999 483 487
18. D.M. Stearns, S.M. Silveira, K.K. Wolf, and A.M. Luke Chromium (III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells Mutat. Res. 513 2002 135 142
19. D.M. Stearns, J.P. Wise, S.R. Patierno, and K.E. Wetterhahn Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells FASEB J. 9 1995 1643 1648
20. M. Stella, A. Montaldi, R. Rossi, G. Rossi, and A.G. Levis Clastogenic effects of chromium on human lymphocytes in vitro and in vivo Mutat. Res. 101 1982 151 164
21. M. Umeda, and M. Nishimura Inducibility of chromosomal aberrations by metal compounds in cultured mammalian cells Mutat. Res. 67 1979 221 229
22. J.B. Vincent Mechanisms of chromium action: low-molecular-weight chromium-binding substance J. Amer. Coll. Nutr. 18 1999 6 12
23. R.F. Whiting, H.F. Stich, and D.J. Koropatnick DNA damage and DNA repair in cultured human cells exposed to chromate Chem. Biol. Interact. 26 1979 267 280